Skip to Main content Skip to Navigation
Journal articles

Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.

Abstract : Meningococcal gyrA gene sequence data, MICs, and mouse infection were used to define the ciprofloxacin breakpoint for Neisseria meningitidis. Residue T91 or D95 of GyrA was altered in all meningococcal isolates with MICs of ≥ 0.064 μg/ml but not among isolates with MICs of ≤ 0.032 μg/ml. Experimental infection of ciprofloxacin-treated mice showed slower bacterial clearance when GyrA was altered. These data suggest a MIC of ≥ 0.064 μg/ml as the ciprofloxacin breakpoint for meningococci and argue for the molecular detection of ciprofloxacin resistance.
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-02089320
Contributor : Marie Martin <>
Submitted on : Wednesday, April 3, 2019 - 4:09:34 PM
Last modification on : Wednesday, October 14, 2020 - 4:15:00 AM

Links full text

Identifiers

Collections

Citation

Eva Hong, Sara Thulin Hedberg, Raquel Abad, Cecilia Fazio, Rocío Enríquez, et al.. Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2013, 57 (4), pp.1961-1964. ⟨10.1128/AAC.02184-12⟩. ⟨pasteur-02089320⟩

Share

Metrics

Record views

87